Filing Details
- Accession Number:
- 0001144204-18-031446
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2018-05-29 21:12:15
- Reporting Period:
- 2018-05-23
- Accepted Time:
- 2018-05-29 21:12:15
- Original Submission Date:
- 2018-05-25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1069899 | Phibro Animal Health Corp | PAHC | Pharmaceutical Preparations (2834) | 131840497 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1601607 | Bfi Co., Llc | 300 Frank W. Burr Blvd., Ste 21 Teaneck NJ 07666 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Stock | Acquisiton | 2018-05-23 | 58,000 | $0.00 | 60,070 | No | 4 | C | Direct | |
Class A Common Stock | Disposition | 2018-05-23 | 1,900 | $45.12 | 58,170 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2018-05-24 | 600 | $45.01 | 57,570 | No | 4 | S | Direct | |
Class A Common Stock | Disposition | 2018-05-25 | 100 | $45.05 | 57,470 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Stock | Class B Common Stock | Disposition | 2018-05-23 | 58,000 | $0.00 | 58,000 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
20,458,034 | No | 4 | C | Direct |
Footnotes
- Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, and has no expiration date.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2017.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.38, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.05, inclusive.